Biovie Inc. SEC filings BIVI
Biovie Inc. has 507 filings in SEC EDGAR's recent list, going back to Jul 2, 2013. Its latest annual report, Form 10-K, was filed on Aug 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 11, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (material agreement). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Nov 5, 2026 | — |
| 424B5 | Prospectus supplement | Nov 5, 2026 | — |
| 424B5 | Prospectus supplement | Nov 4, 2026 | — |
| DEF 14A | Proxy statement | Sep 28, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 14, 2026 | Sep 11, 2026 |
| 424B5 | Prospectus supplement | Sep 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 3, 2026 | — |
| 4 | Insider transaction | Aug 28, 2026 | Aug 28, 2026 |
| 4 | Insider transaction | Aug 28, 2026 | Aug 28, 2026 |
| 4 | Insider transaction | Aug 28, 2026 | Aug 28, 2026 |
| 4 | Insider transaction | Aug 28, 2026 | Aug 27, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 19, 2026 | — |
| S-1/A | Amended registration statement | Aug 14, 2026 | — |
| 10-K | Annual report | Aug 13, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 7, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| FWP | Free writing prospectus | Aug 7, 2026 | — |
| FWP | Free writing prospectus | Aug 6, 2026 | — |
| FWP | Free writing prospectus | Aug 6, 2026 | — |
| S-1/A | Amended registration statement | Aug 6, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| S-1/A | Amended registration statement | Jul 31, 2026 | — |
| S-1 | Registration statement | Jul 17, 2026 | — |
| EFFECT | Filing | Jun 29, 2026 | — |
| S-3 | Shelf registration | Jun 18, 2026 | — |
| DRS | Filing | Jun 11, 2026 | — |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Mar 25, 2026 | — |
| 10-Q | Quarterly report | Feb 6, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 5, 2026 |
| S-8 | Employee stock plan registration | Nov 25, 2025 | — |
| EFFECT | Filing | Nov 18, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Nov 13, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Nov 12, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 3 | Initial insider ownership | Oct 28, 2025 | Jul 17, 2025 |
| 3 | Initial insider ownership | Oct 27, 2025 | Jul 17, 2025 |
| POS AM | Filing | Oct 6, 2025 | — |
| POS EX | Filing | Oct 6, 2025 | — |
| 424B3 | Prospectus | Oct 6, 2025 | — |
| DEF 14A | Proxy statement | Sep 25, 2025 | Sep 25, 2025 |
| 10-K | Annual report | Aug 15, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 11, 2025 | Aug 7, 2025 |
| 424B5 | Prospectus supplement | Aug 8, 2025 | — |
| EFFECT | Filing | Aug 7, 2025 | — |
| CERT | Filing | Aug 7, 2025 | — |
| 8-A12B | Form 8-a12b | Aug 7, 2025 | — |
| CORRESP | Letter to the SEC | Aug 4, 2025 | — |
| CORRESP | Letter to the SEC | Aug 4, 2025 | — |
| S-1/A | Amended registration statement | Aug 4, 2025 | — |
| CORRESP | Letter to the SEC | Jul 24, 2025 | — |
| CORRESP | Letter to the SEC | Jul 24, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 23, 2025 | Jul 17, 2025 |
| CORRESP | Letter to the SEC | Jul 22, 2025 | — |
| CORRESP | Letter to the SEC | Jul 22, 2025 | — |
| S-1/A | Amended registration statement | Jul 22, 2025 | — |
| S-1/A | Amended registration statement | Jul 11, 2025 | — |
| S-1 | Registration statement | Jul 3, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 30, 2025 | — |
| 8-K |
Current report
Change to shareholder rights
|
Jun 27, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2025 | Jun 23, 2025 |
| DEF 14A | Proxy statement | Jun 2, 2025 | Jun 2, 2025 |
| UPLOAD | Letter from the SEC | May 20, 2025 | — |
| DRS | Filing | May 15, 2025 | — |
| DRSLTR | Filing | May 14, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| PRE 14A | Preliminary proxy statement | May 8, 2025 | May 8, 2025 |
| PRE 14C | Filing | May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 28, 2025 | Mar 28, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 11, 2025 | — |
| 10-Q | Quarterly report | Feb 11, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 7, 2025 | Nov 20, 2024 |
| 4 | Insider transaction | Jan 7, 2025 | Nov 20, 2024 |
| 4 | Insider transaction | Jan 7, 2025 | Nov 20, 2024 |
| 4 | Insider transaction | Jan 7, 2025 | Nov 20, 2024 |
| 4 | Insider transaction | Jan 7, 2025 | Nov 20, 2024 |
| 4 | Insider transaction | Jan 7, 2025 | Dec 20, 2024 |
| 4 | Insider transaction | Jan 7, 2025 | Dec 20, 2024 |
| 4 | Insider transaction | Jan 7, 2025 | Dec 20, 2024 |
| 1-A | Filing | Dec 31, 2024 | — |
| EFFECT | Filing | Dec 2, 2024 | — |
| 424B3 | Prospectus | Dec 2, 2024 | — |
| CORRESP | Letter to the SEC | Nov 29, 2024 | — |
| S-1/A | Amended registration statement | Nov 27, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 26, 2024 | — |
| S-8 | Employee stock plan registration | Nov 22, 2024 | — |
| S-1 | Registration statement | Nov 21, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Nov 8, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 29, 2024 | Oct 28, 2024 |
| 424B5 | Prospectus supplement | Oct 29, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 29, 2024 | Oct 28, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 25, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 24, 2024 | Oct 23, 2024 |
| 424B5 | Prospectus supplement | Oct 24, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 24, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 22, 2024 | Oct 22, 2024 |
| 424B5 | Prospectus supplement | Oct 22, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 22, 2024 | Oct 21, 2024 |
| DEFA14A | Additional proxy material | Oct 22, 2024 | — |
| 10-K | Annual report | Sep 30, 2024 | Jun 30, 2024 |
| DEF 14A | Proxy statement | Sep 27, 2024 | Sep 27, 2024 |
| 424B5 | Prospectus supplement | Sep 25, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 25, 2024 | Sep 25, 2024 |
| 424B5 | Prospectus supplement | Sep 24, 2024 | — |
| 8-K/A | Amended current report | Sep 24, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 24, 2024 | Sep 23, 2024 |
| 424B5 | Prospectus supplement | Sep 23, 2024 | — |
| PRE 14A | Preliminary proxy statement | Sep 17, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Other events
|
Aug 21, 2024 | Aug 20, 2024 |
| 8-K/A |
Amended current report
Change to shareholder rights, Bylaw or fiscal year change
|
Aug 6, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Aug 1, 2024 | Jul 29, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 30, 2024 | Jul 25, 2024 |
| 4 | Insider transaction | Jul 12, 2024 | Feb 16, 2023 |
| 4 | Insider transaction | Jul 12, 2024 | Feb 16, 2023 |
| 4 | Insider transaction | Jul 12, 2024 | Feb 16, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Jun 25, 2024 | — |
| DEF 14A | Proxy statement | Jun 17, 2024 | Jun 17, 2024 |
| PRE 14A | Preliminary proxy statement | Jun 7, 2024 | Jun 7, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Listing notice
|
Apr 19, 2024 | Apr 18, 2024 |
| UPLOAD | Letter from the SEC | Apr 5, 2024 | — |
| CORRESP | Letter to the SEC | Mar 15, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 11, 2024 | Mar 11, 2024 |
| 4 | Insider transaction | Mar 6, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 6, 2024 | Mar 6, 2024 |
| 8-K/A | Amended current report | Mar 4, 2024 | Mar 4, 2024 |
| 424B5 | Prospectus supplement | Mar 4, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 424B5 | Prospectus supplement | Mar 1, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 1, 2024 | Mar 1, 2024 |
| 10-Q | Quarterly report | Feb 13, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Jan 25, 2024 | Jan 19, 2024 |
| 8-K |
Current report
Other events
|
Jan 19, 2024 | Jan 19, 2024 |
| 424B3 | Prospectus | Jan 19, 2024 | — |
| 4 | Insider transaction | Dec 13, 2023 | Dec 11, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Nov 9, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Nov 9, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Nov 9, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Nov 9, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Nov 9, 2023 |
| 4 | Insider transaction | Dec 6, 2023 | Nov 9, 2023 |
| 4 | Insider transaction | Dec 1, 2023 | Nov 30, 2023 |
| 144 | Notice of proposed sale | Dec 1, 2023 | — |
| 144 | Notice of proposed sale | Dec 1, 2023 | — |
| 8-K |
Current report
Other events
|
Nov 29, 2023 | Nov 29, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Nov 13, 2023 | Nov 8, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Other events
|
Oct 25, 2023 | Oct 25, 2023 |
| DEF 14A | Proxy statement | Sep 29, 2023 | Sep 29, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2023 | Sep 8, 2023 |
| 4 | Insider transaction | Sep 7, 2023 | Sep 5, 2023 |
| 144 | Notice of proposed sale | Sep 5, 2023 | — |
| 424B3 | Prospectus | Aug 29, 2023 | — |
| EFFECT | Filing | Aug 28, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2023 | — |
| 4 | Insider transaction | Aug 24, 2023 | Aug 22, 2023 |
| CORRESP | Letter to the SEC | Aug 24, 2023 | — |
| S-3 | Shelf registration | Aug 18, 2023 | — |
| 10-K | Annual report | Aug 16, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jun 7, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jun 29, 2023 |
| 4 | Insider transaction | Jul 3, 2023 | Jun 7, 2023 |
| 4 | Insider transaction | Jun 26, 2023 | Jun 21, 2023 |
| 4 | Insider transaction | Jun 15, 2023 | May 22, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 424B3 | Prospectus | Apr 14, 2023 | — |
| EFFECT | Filing | Apr 10, 2023 | — |
| CORRESP | Letter to the SEC | Apr 7, 2023 | — |
| 424B5 | Prospectus supplement | Apr 7, 2023 | — |
| 8-K |
Current report
Other events
|
Apr 7, 2023 | Apr 6, 2023 |
| 4 | Insider transaction | Apr 6, 2023 | Mar 27, 2023 |
| UPLOAD | Letter from the SEC | Apr 6, 2023 | — |
| CORRESP | Letter to the SEC | Apr 6, 2023 | — |
| S-3 | Shelf registration | Mar 31, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 23, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 13, 2023 | Mar 12, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 10, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Mar 7, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Mar 6, 2023 | Mar 2, 2023 |
| 4 | Insider transaction | Feb 22, 2023 | Feb 16, 2023 |
| 4 | Insider transaction | Feb 22, 2023 | Feb 16, 2023 |
| 4 | Insider transaction | Feb 22, 2023 | Feb 16, 2023 |
| 4 | Insider transaction | Feb 22, 2023 | Feb 16, 2023 |
| 4 | Insider transaction | Feb 22, 2023 | Feb 16, 2023 |
| 4 | Insider transaction | Feb 22, 2023 | Feb 16, 2023 |
| 10-Q | Quarterly report | Feb 10, 2023 | Dec 31, 2022 |
| 4 | Insider transaction | Jan 18, 2023 | Nov 23, 2022 |
| 4 | Insider transaction | Jan 18, 2023 | Nov 23, 2022 |
| 4 | Insider transaction | Jan 18, 2023 | Nov 23, 2022 |
| 4 | Insider transaction | Jan 18, 2023 | Nov 23, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BIVI (Nasdaq), BIVIW (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- NV
- Headquarters
- Carson City, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1580149
- Former names
- NANOANTIBIOTICS, INC. (until Jul 22, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.